In patients with heart failure and sarcopenia, the level of growth hormone (GH) is increased, while the level of insulin-like growth factor-1(IGF-1) is significantly reduced, suggesting that there may be GH resistance, leading to an inhibition of skeletal muscle formation. Here, GH1 is linked to sarcopenia.